Jump to content

Inocoterone

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Bender the Bot (talk | contribs) at 04:23, 3 October 2016 (top: http→https for Google Books and Google News using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Inocoterone
Clinical data
Routes of
administration
Topical
Identifiers
  • (3S,3aS,9aS,9bS)-6-Ethyl-3-hydroxy-3a-methyl-2,3,4,5,8,9,9a,9b-octahydro-1H-cyclopenta[a]naphthalen-7-one
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC16H24O2
Molar mass248.36056 g/mol g·mol−1
3D model (JSmol)
  • CCC1=C2CCC3(C(C2CCC1=O)CCC3O)C
  • InChI=1S/C16H24O2/c1-3-10-11-8-9-16(2)13(5-7-15(16)18)12(11)4-6-14(10)17/h12-13,15,18H,3-9H2,1-2H3/t12-,13+,15+,16+/m1/s1
  • Key:DOTDLCMVUVGSDP-VRKREXBASA-N

Inocoterone (INN), or as inocoterone acetate (USAN) (developmental code names RU-882, RU-38882), also known as 17β-hydroxy-2,5-seco-A-dinorestr-9-en-5-one [acetate], is a non-steroidal antiandrogen that was developed in 1985 for topical administration but was never marketed.[1][2][3] It was investigated for the treatment of acne but showed only modest (albeit statistically significant) efficacy in clinical trials.[4][5] A reduction of 26% of lesions was observed in males treated with the drug after 16 weeks (~3.7 months).[5][6] However, this is notably far less than that achieved with other agents such as benzoyl peroxide or antibiotics, which produce 50–75% reductions within 2 months.[6] Similar poor results with the topical route have disappointingly been found for other antiandrogens such as cyproterone acetate and spironolactone.[6]

See also

References

  1. ^ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 686–. ISBN 978-1-4757-2085-3.
  2. ^ P. Michael Conn (23 July 2010). Techniques in Confocal Microscopy. Academic Press. pp. 215–. ISBN 978-0-12-384659-4.
  3. ^ Annual Reports in Medicinal Chemistry. Academic Press. 2 September 1987. pp. 358–. ISBN 978-0-08-058366-2.
  4. ^ Leo Plouffe, Jr; Botros R. M. B. Rizk (25 June 2015). Androgens in Gynecological Practice. Cambridge University Press. pp. 84–. ISBN 978-1-316-29887-9.
  5. ^ a b Lookingbill, D. P. (1992). "Inocoterone and acne. The effect of a topical antiandrogen: results of a multicenter clinical trial". Archives of Dermatology. 128 (9): 1197–1200. doi:10.1001/archderm.128.9.1197. ISSN 0003-987X.
  6. ^ a b c Richard A. Helms; David J. Quan (2006). Textbook of Therapeutics: Drug and Disease Management. Lippincott Williams & Wilkins. pp. 211–. ISBN 978-0-7817-5734-8.